ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L02AE02 | B | Leuprorelin acetate - 22.5mg | 11627 | 94322/1 | ELIGARD | 22.5mg | 1+1 | Injectable powder for solution+diluent | SC | Mersaco | Tolmar Inc. | USA | 17,678,335 L.L | 19.35 | D | Tolmar Therapeutics Inc. | USA | 05/02/20 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L02AE02 | B | Leuprorelin acetate - 22.5mg | 6803 | 97965/12 | ELIGARD | 22.5mg | 1+1 | Injectable powder for solution+diluent | SC | Mersaco | Astellas Pharma Europe BV | The Netherlands | 17,678,335 L.L | 19.35 | D | Astellas Pharma Europe BV | The Netherlands | 05/02/20 | 0 |